ArticleNature communications2025
Stereoselective diversification of α-amino acids enabled by N-heterocyclic carbene catalysis.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immobilized Wild-Type and Mutant L‑Alanine Dehydrogenase fromACS omega · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chiral α-amino acids (AAs), essential to biological systems and drug design, drive demand for precise synthetic methods to access unnatural variants (UAAs) and stereochemically defined peptides. We report an N-heterocyclic carbene (NHC)-catalyzed strategy enabling enantioselective synthesis of α-(U)AA esters and peptides. Leveraging NHC-generated acyl azolium intermediates, this approach achieves dynamic kinetic resolution of racemic or chiral α-(U)AAs with broad substrate scope, including sterically hindered and unsaturated derivatives. Stereodivergent synthesis is accomplished via NHC-mediated proton shuttling, which usually furnishes enantio-complementary α-(U)AAs and peptides with >90% ee (de). Mechanistic studies establish that N,N'-diisopropylcarbodiimide activates α-(U)AAs to form oxazolone intermediates, which undergo NHC-mediated conversion to acyl azolium species. Divergent nucleophilic pathways are governed by chiral matching between catalyst and substrate, as evidenced by density functional theory (DFT) calculations revealing π-π interactions and steric effects as stereoselectivity determinants. The methodology's utility is also demonstrated in solid-phase peptide synthesis, achieving direct chirality transfer from racemic precursors to peptides with minimal epimerization. This work provides a catalytic platform for stereocontrolled α-(U)AA and peptide synthesis, with implications for chemical biology and peptide therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.